FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012809609> ?p ?o ?g. }

• W2012809609 abstract "A specific nutrient mixture (NM) containing lysine, proline, ascorbic acid and green tea extract has demonstrated a broad spectrum of antitumor activity against a number of cancer cell lines. In this study, our main objective was to investigate the comparative effects of NM on anticancer parameters, such as cytotoxicity, matrix metalloproteinase (MMP) secretion and Matrigel invasion in the human uterine sarcoma drug-resistant MES-SA/Dx5 and the drug-sensitive MES-SA cell lines. In addition we studied the effects of NM on P-glycoprotein (Pgp) on these cell lines. Cell proliferation was evaluated by MTT assay, MMPs by gelatinase zymography, invasion through Matrigel, morphology by H&E and Pgp expression by Western blot analysis and immunodetection using FITC-conjugated antibody and rhodamine 123 (Rh123) accumulation and efflux assays. NM exhibited antiproliferative effects on MES-SA/Dx5, by 20% at 50 and 100 µg/ml and by 36, 40 and 48% at 250, 500 and 1,000 µg/ml, respectively. By contrast, NM treatment of MES-SA cells resulted in significantly increased cytotoxicity: 40, 46, 65 and 72% at 50, 100, 500 and 1,000 µg/ml, respectively. In both cell lines, zymography demonstrated a band corresponding to MMP-2 in normal cells and MMP-9 with phorbol 12-myristate 13-acetate treatment. The two MMPs showed dose-response inhibition by NM. As shown by Western blot analysis and immunodetection, NM treatment resulted in a dose-dependent decrease in Pgp expression in the MES-SA/Dx5 cell line. The MES-SA cell line does not exhibit Pgp. NM enhanced the accumulation and efflux of the Pgp substrate, Rh123, in the MES-SA/Dx5 uterine sarcoma cell line but not in the drug-sensitive cell line, MES-SA. Therefore, it can be concluded that NM demonstrates potent anticancer effects in both the drug-resistant and sensitive cell lines and modulates Pgp, suggesting its potential therapeutic effects in drug-resistant as well as sensitive cancers." @default.
• W2012809609 created "2016-06-24" @default.
• W2012809609 creator A5003848269 @default.
• W2012809609 creator A5004182768 @default.
• W2012809609 creator A5075296153 @default.
• W2012809609 creator A5078266408 @default.
• W2012809609 creator A5086331722 @default.
• W2012809609 date "2011-09-22" @default.
• W2012809609 modified "2023-10-16" @default.
• W2012809609 title "Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines" @default.
• W2012809609 cites W133227232 @default.
• W2012809609 cites W1658247921 @default.
• W2012809609 cites W1830974569 @default.
• W2012809609 cites W1866029529 @default.
• W2012809609 cites W1925657344 @default.
• W2012809609 cites W1969387253 @default.
• W2012809609 cites W1969515134 @default.
• W2012809609 cites W2005351832 @default.
• W2012809609 cites W2008469349 @default.
• W2012809609 cites W2014887256 @default.
• W2012809609 cites W2030275883 @default.
• W2012809609 cites W2033346155 @default.
• W2012809609 cites W2037026342 @default.
• W2012809609 cites W2040636059 @default.
• W2012809609 cites W2042555459 @default.
• W2012809609 cites W2065068389 @default.
• W2012809609 cites W2066064778 @default.
• W2012809609 cites W2066439036 @default.
• W2012809609 cites W2068233575 @default.
• W2012809609 cites W2075851548 @default.
• W2012809609 cites W2092324642 @default.
• W2012809609 cites W2105697161 @default.
• W2012809609 cites W2108304991 @default.
• W2012809609 cites W2114915163 @default.
• W2012809609 cites W2127718764 @default.
• W2012809609 cites W2128396634 @default.
• W2012809609 cites W2134795955 @default.
• W2012809609 cites W2141537184 @default.
• W2012809609 cites W2148710732 @default.
• W2012809609 cites W2157653515 @default.
• W2012809609 cites W2167996003 @default.
• W2012809609 cites W2949407848 @default.
• W2012809609 cites W37481061 @default.
• W2012809609 cites W7268420 @default.
• W2012809609 cites W84182309 @default.
• W2012809609 cites W1735703025 @default.
• W2012809609 doi "https://doi.org/10.3892/or.2011.1471" @default.
• W2012809609 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21947138" @default.
• W2012809609 hasPublicationYear "2011" @default.
• W2012809609 type Work @default.
• W2012809609 sameAs 2012809609 @default.
• W2012809609 citedByCount "2" @default.
• W2012809609 countsByYear W20128096092015 @default.
• W2012809609 countsByYear W20128096092023 @default.
• W2012809609 crossrefType "journal-article" @default.
• W2012809609 hasAuthorship W2012809609A5003848269 @default.
• W2012809609 hasAuthorship W2012809609A5004182768 @default.
• W2012809609 hasAuthorship W2012809609A5075296153 @default.
• W2012809609 hasAuthorship W2012809609A5078266408 @default.
• W2012809609 hasAuthorship W2012809609A5086331722 @default.
• W2012809609 hasBestOaLocation W20128096091 @default.
• W2012809609 hasConcept C104317684 @default.
• W2012809609 hasConcept C109316439 @default.
• W2012809609 hasConcept C109523444 @default.
• W2012809609 hasConcept C133936738 @default.
• W2012809609 hasConcept C1491633281 @default.
• W2012809609 hasConcept C153911025 @default.
• W2012809609 hasConcept C177430391 @default.
• W2012809609 hasConcept C202751555 @default.
• W2012809609 hasConcept C2776415932 @default.
• W2012809609 hasConcept C2778589691 @default.
• W2012809609 hasConcept C2778608917 @default.
• W2012809609 hasConcept C2780783641 @default.
• W2012809609 hasConcept C29537977 @default.
• W2012809609 hasConcept C501593827 @default.
• W2012809609 hasConcept C54355233 @default.
• W2012809609 hasConcept C55493867 @default.
• W2012809609 hasConcept C81885089 @default.
• W2012809609 hasConcept C86803240 @default.
• W2012809609 hasConceptScore W2012809609C104317684 @default.
• W2012809609 hasConceptScore W2012809609C109316439 @default.
• W2012809609 hasConceptScore W2012809609C109523444 @default.
• W2012809609 hasConceptScore W2012809609C133936738 @default.
• W2012809609 hasConceptScore W2012809609C1491633281 @default.
• W2012809609 hasConceptScore W2012809609C153911025 @default.
• W2012809609 hasConceptScore W2012809609C177430391 @default.
• W2012809609 hasConceptScore W2012809609C202751555 @default.
• W2012809609 hasConceptScore W2012809609C2776415932 @default.
• W2012809609 hasConceptScore W2012809609C2778589691 @default.
• W2012809609 hasConceptScore W2012809609C2778608917 @default.
• W2012809609 hasConceptScore W2012809609C2780783641 @default.
• W2012809609 hasConceptScore W2012809609C29537977 @default.
• W2012809609 hasConceptScore W2012809609C501593827 @default.
• W2012809609 hasConceptScore W2012809609C54355233 @default.
• W2012809609 hasConceptScore W2012809609C55493867 @default.
• W2012809609 hasConceptScore W2012809609C81885089 @default.
• W2012809609 hasConceptScore W2012809609C86803240 @default.
• W2012809609 hasLocation W20128096091 @default.
• W2012809609 hasLocation W20128096092 @default.
• W2012809609 hasOpenAccess W2012809609 @default.

• next